Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum

Frank Brodie; Michael Repka; Stephen Allan Burns; S. Grace Prakalapakorn; Christie Morse; Joel S. Schuman; Michael R. Duenas; Natalie Afshari; John S. Pollack; Jennifer E. Thorne; Albert Vitale; H. Nida Sen; David Myung; Mark S. Blumenkranz; Elmer Tu; Daniel X. Hammer; Michelle Tarver; Bradley Cunningham; Larry Kagemann; Srini Vas Sadda; David Sarraf; Glenn J. Jaffe; Malvina Eydelman

doi:10.1001/jamaophthalmol.2020.4994

Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum

Frank Brodie, Michael Repka, Stephen Allan Burns, S. Grace Prakalapakorn, Christie Morse, Joel S. Schuman, Michael R. Duenas, Natalie Afshari, John S. Pollack, Jennifer E. Thorne, Albert Vitale, H. Nida Sen, David Myung, Mark S. Blumenkranz, Elmer Tu, Daniel X. Hammer, Michelle Tarver, Bradley Cunningham, Larry Kagemann, Srini Vas SaddaDavid Sarraf, Glenn J. Jaffe, Malvina Eydelman

Research output: Contribution to journal › Review article › peer-review

Abstract

In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.

Original language	English (US)
Pages (from-to)	113-118
Number of pages	6
Journal	JAMA ophthalmology
Volume	139
Issue number	1
DOIs	https://doi.org/10.1001/jamaophthalmol.2020.4994
State	Published - Jan 2021
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1001/jamaophthalmol.2020.4994

Cite this

Brodie, F., Repka, M., Burns, S. A., Prakalapakorn, S. G., Morse, C., Schuman, J. S., Duenas, M. R., Afshari, N., Pollack, J. S., Thorne, J. E., Vitale, A., Sen, H. N., Myung, D., Blumenkranz, M. S., Tu, E., Hammer, D. X., Tarver, M., Cunningham, B., Kagemann, L., ... Eydelman, M. (2021). Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum. JAMA ophthalmology, 139(1), 113-118. https://doi.org/10.1001/jamaophthalmol.2020.4994

Brodie, F, Repka, M, Burns, SA, Prakalapakorn, SG, Morse, C, Schuman, JS, Duenas, MR, Afshari, N, Pollack, JS, Thorne, JE, Vitale, A, Sen, HN, Myung, D, Blumenkranz, MS, Tu, E, Hammer, DX, Tarver, M, Cunningham, B, Kagemann, L, Sadda, SV, Sarraf, D, Jaffe, GJ & Eydelman, M 2021, 'Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum', JAMA ophthalmology, vol. 139, no. 1, pp. 113-118. https://doi.org/10.1001/jamaophthalmol.2020.4994

@article{f98ad62a648e4d569868bc186081dc26,

title = "Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum",

abstract = "In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.",

author = "Frank Brodie and Michael Repka and Burns, {Stephen Allan} and Prakalapakorn, {S. Grace} and Christie Morse and Schuman, {Joel S.} and Duenas, {Michael R.} and Natalie Afshari and Pollack, {John S.} and Thorne, {Jennifer E.} and Albert Vitale and Sen, {H. Nida} and David Myung and Blumenkranz, {Mark S.} and Elmer Tu and Hammer, {Daniel X.} and Michelle Tarver and Bradley Cunningham and Larry Kagemann and Sadda, {Srini Vas} and David Sarraf and Jaffe, {Glenn J.} and Malvina Eydelman",

year = "2021",

month = jan,

doi = "10.1001/jamaophthalmol.2020.4994",

language = "English (US)",

volume = "139",

pages = "113--118",

journal = "JAMA ophthalmology",

issn = "2168-6165",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging

T2 - Report from a US Food and Drug Administration-Cosponsored Forum

AU - Brodie, Frank

AU - Repka, Michael

AU - Burns, Stephen Allan

AU - Prakalapakorn, S. Grace

AU - Morse, Christie

AU - Schuman, Joel S.

AU - Duenas, Michael R.

AU - Afshari, Natalie

AU - Pollack, John S.

AU - Thorne, Jennifer E.

AU - Vitale, Albert

AU - Sen, H. Nida

AU - Myung, David

AU - Blumenkranz, Mark S.

AU - Tu, Elmer

AU - Hammer, Daniel X.

AU - Tarver, Michelle

AU - Cunningham, Bradley

AU - Kagemann, Larry

AU - Sadda, Srini Vas

AU - Sarraf, David

AU - Jaffe, Glenn J.

AU - Eydelman, Malvina

PY - 2021/1

Y1 - 2021/1

N2 - In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.

AB - In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.

UR - http://www.scopus.com/inward/record.url?scp=85096718884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096718884&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2020.4994

DO - 10.1001/jamaophthalmol.2020.4994

M3 - Review article

C2 - 33211074

AN - SCOPUS:85096718884

SN - 2168-6165

VL - 139

SP - 113

EP - 118

JO - JAMA ophthalmology

JF - JAMA ophthalmology

IS - 1

ER -

Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report from a US Food and Drug Administration-Cosponsored Forum

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this